FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 161 filers reported holding FATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,366,000 | +26.4% | 125,000 | -44.4% | 0.54% | -18.4% |
Q3 2020 | $8,993,000 | +16.5% | 225,000 | 0.0% | 0.66% | +6.6% |
Q2 2020 | $7,720,000 | -22.8% | 225,000 | -50.0% | 0.62% | +5.1% |
Q1 2020 | $9,994,000 | +127.0% | 450,000 | +100.0% | 0.59% | +16.7% |
Q4 2019 | $4,403,000 | +26.0% | 225,000 | 0.0% | 0.50% | +29.6% |
Q3 2019 | $3,494,000 | -42.6% | 225,000 | -25.0% | 0.39% | -29.8% |
Q2 2019 | $6,090,000 | -12.2% | 300,000 | -24.1% | 0.55% | -11.9% |
Q1 2019 | $6,940,000 | +33.6% | 395,000 | -2.5% | 0.63% | +99.7% |
Q4 2018 | $5,196,000 | -50.9% | 405,000 | -37.7% | 0.32% | -54.1% |
Q3 2018 | $10,585,000 | +25.5% | 649,800 | -12.7% | 0.69% | +20.5% |
Q2 2018 | $8,437,000 | -13.0% | 744,011 | -25.1% | 0.57% | -33.5% |
Q1 2018 | $9,699,000 | +85.9% | 993,711 | +16.4% | 0.86% | +94.8% |
Q4 2017 | $5,217,000 | +94.1% | 853,800 | +25.8% | 0.44% | +56.0% |
Q3 2017 | $2,688,000 | +41.0% | 678,800 | +15.4% | 0.28% | +0.4% |
Q2 2017 | $1,906,000 | -10.9% | 588,237 | +25.2% | 0.28% | -15.4% |
Q1 2017 | $2,139,000 | – | 470,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |